Publications by authors named "John McVey"

Article Synopsis
  • Post-liver transplant (LT) patients require immunosuppression to avoid organ rejection, but this increases the risk of tumor recurrence, particularly for patients with hepatocellular carcinoma (HCC).
  • This study analyzed data from 1,406 HCC patients who underwent LT to assess the impact of varying levels of tacrolimus (FK) immunosuppression on cancer recurrence, finding that FK levels measured two weeks post-transplant were significantly associated with recurrence risk.
  • Results indicate that personalized immunosuppression strategies should consider the timing and individual patient's risk factors (like tumor characteristics) to optimize outcomes after LT.
View Article and Find Full Text PDF

Background: The intimal hyperplasia (IH) and vascular remodelling that follows endovascular injury, for instance after post-angioplasty re-stenosis, results in downstream ischaemia and progressive end organ damage. Interferon gamma (IFNγ) is known to play a critical role in this process. In mouse models we have previously shown that fibrocytes expressing tissue factor (TF) are recruited early to the site of injury.

View Article and Find Full Text PDF

Background & Aims: Continuous risk-stratification of candidates and urgency-based prioritization have been utilized for liver transplantation (LT) in patients with non-hepatocellular carcinoma (HCC) in the United States. Instead, for patients with HCC, a dichotomous criterion with exception points is still used. This study evaluated the utility of the hazard associated with LT for HCC (HALT-HCC), an oncological continuous risk score, to stratify waitlist dropout and post-LT outcomes.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the limited effectiveness of immune checkpoint inhibitors (ICI) for liver cancer, specifically focusing on the role of adenosine signaling and A2a receptor (A2aR) inhibition combined with anti-PD1 therapy in mouse models.
  • Researchers analyzed RNA expression related to the adenosine pathway, examined immune cells from liver cancer patients, and used various mouse models to test the combination therapy.
  • Results showed that combining A2aR inhibition with anti-PD1 therapy can significantly enhance T cell activation and reduce tumor size in liver cancer models, suggesting this approach could improve treatment outcomes for patients.
View Article and Find Full Text PDF

Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) have the potential to remuscularize infarcted hearts but their arrhythmogenicity remains an obstacle to safe transplantation. Myofibroblasts are the predominant cell-type in the infarcted myocardium but their impact on transplanted hiPSC-CMs remains poorly defined. Here, we investigate the effect of myofibroblasts on hiPSC-CMs electrophysiology and Ca handling using optical mapping of advanced human cell coculture systems mimicking cell-cell interaction modalities.

View Article and Find Full Text PDF
Article Synopsis
  • * Fecal transplantation shows that this iNKT regulation is linked to microbiome changes rather than simply increasing the number of iNKT cells; it indicates an indirect effect since in vitro activated iNKT cells from vancomycin-treated mice do not exhibit increased activation.
  • * The findings reveal that IL-18 from liver macrophages, particularly those expressing CSF-1R, is crucial for the enhanced iNKT activation, highlighting the gut microbiome's role in regulating immune response through these macrophages.
View Article and Find Full Text PDF

Vascular disease forms the basis of most cardiovascular diseases (CVDs), which remain the primary cause of mortality and morbidity worldwide. Efficacious surgical and pharmacological interventions to prevent and treat vascular disease are urgently needed. In part, the shortage of translational models limits the understanding of the cellular and molecular processes involved in vascular disease.

View Article and Find Full Text PDF

Femoral artery (FA) endothelial function is a promising biomarker of lower extremity vascular health for peripheral artery disease (PAD) prevention and treatment; however, the impact of age on FA endothelial function has not been reported in healthy adults. Therefore, we evaluated the reproducibility and acceptability of flow-mediated dilation (FMD) in the FA and brachial artery (BA) (n = 20) and performed cross-sectional FA- and BA-FMD measurements in healthy non-smokers aged 22−76 years (n = 50). FMD protocols demonstrated similar good reproducibility.

View Article and Find Full Text PDF

Background: Routine chemical venous thromboembolism (VTE) prophylaxis for liver surgery remains controversial, and often delayed post-operatively due to perceived bleeding risk. This study asked whether patients undergoing hepatectomy for colorectal metastases (CRM) were at risk from VTE pre-operatively, and the impact of hepatectomy on that risk.

Methods: Single-centre prospective observational cohort study of patients undergoing open hepatectomy for CRM, comparing pre-, peri- and post-operative haemostatic variables.

View Article and Find Full Text PDF

Background: Tissue factor (TF) generates proteases that can signal through PAR-1 and PAR-2. We have previously demonstrated PAR-1 signalling primes innate myeloid cells to be exquisitely sensitive to interferon-gamma (IFNγ). In this work we explored how TF mediated PAR-2 signalling modulated responsiveness to IFNγ and investigated the interplay between PAR-1/-2 signalling on macrophages.

View Article and Find Full Text PDF

: diabetes and age are major risk factors for the development of lower extremity peripheral artery disease (PAD). Cocoa flavanol (CF) consumption is associated with lower risk for PAD and improves brachial artery (BA) endothelial function. : to assess if femoral artery (FA) endothelial function and dermal microcirculation are impaired in individuals with type 2 diabetes mellitus (T2DM) and evaluate the acute effect of CF consumption on FA endothelial function.

View Article and Find Full Text PDF
Article Synopsis
  • Platelets, often seen as just clotting agents, actually play a surprising role in promoting tumor growth and can also inhibit liver cancer (HCC) in mice with non-alcoholic fatty liver disease (NAFLD).
  • The study showed that the anti-tumor effects of platelets come from their release of CD40L through a pathway involving the P2Y12 receptor, which helps activate CD8 T cells.
  • Unlike traditional anti-platelet medications like aspirin, which don't affect CD40L release, this research suggests that targeting platelets without blocking CD40L could benefit liver cancer patients with NAFLD.
View Article and Find Full Text PDF

Routine interventions such as balloon angioplasty, result in vascular activation and remodeling, often requiring re-intervention. models and small animal experiments have enabled the discovery of important mechanisms involved in this process, however the clinical translation is often underwhelming. There is a critical need for an model representative of the human vascular physiology and encompassing the complexity of the vascular wall and the physical forces regulating its function.

View Article and Find Full Text PDF

Angiogenesis, the formation of new capillaries from existing ones, is a fundamental process in regenerative medicine and tissue engineering. While it is known to be affected by circadian rhythms , its peripheral regulation within the vasculature and the role it performs in regulating the interplay between vascular cells have not yet been investigated. Peripheral clocks within the vasculature have been described in the endothelium and in smooth muscle cells.

View Article and Find Full Text PDF
Article Synopsis
  • - Non-alcoholic steatohepatitis (NASH) is rapidly becoming a leading cause of liver cancer (hepatocellular carcinoma, HCC) and may reduce the effectiveness of immune checkpoint inhibitors (ICI) used for treatment.
  • - Research using mouse models showed that NASH disrupts CD8 T cells' metabolism and mobility, diminishing their response to anti-PD-1 therapy against liver cancer.
  • - Metformin treatment was found to improve the efficacy of anti-PD-1 therapy in liver cancer associated with NASH, indicating potential therapeutic benefits for patients with this condition.
View Article and Find Full Text PDF
Article Synopsis
  • * The study created a specialized cell line to explore how NAFLD influences the immune response to cancer by focusing on CD8 T cells in mouse models.
  • * Results indicated that NAFLD weakens the immune response from CD8 T cells against liver cancer, primarily due to an increase in liver macrophages, suggesting that targeting these macrophages could enhance treatment effectiveness.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how the local environment of cytokines influences innate lymphoid cells (ILCs) in hepatocellular carcinoma (HCC), a cancer linked to inflammation.
  • RNA sequencing and various cellular analyses from HCC samples revealed that cytokine gradients affect ILC types, with changes leading to altered immune functions that may relate to patient survival.
  • High levels of ILC2 compared to ILC1, associated with the presence of interleukin-33, were linked to better survival outcomes, highlighting the tumor's cytokine environment as a critical factor in HCC prognosis.
View Article and Find Full Text PDF

The pathogenic significance of nucleotide variants commonly relies on nucleotide position within the gene, with exonic changes generally attributed to quantitative or qualitative alteration of protein biosynthesis, secretion, activity, or clearance. However, these changes may exert pleiotropic effects on both protein biology and mRNA splicing due to the overlapping of the amino acid and splicing codes, thus shaping the disease phenotypes. Here, we focused on hemophilia A, in which the definition of F8 variants' causative role and association to bleeding phenotypes is crucial for proper classification, genetic counseling, and management of affected individuals.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate the combination of trametinib, a MEK inhibitor, with anti-PD-1 therapy in mouse models of iCCA to enhance treatment efficacy.
  • Results demonstrated that trametinib not only inhibited tumor growth in multiple cell lines but also improved survival rates and reduced tumor burden when combined with anti-PD-1, promoting a more favorable immune response in the tumor microenvironment.
View Article and Find Full Text PDF

The use of livers from donation after circulatory death (DCD) is historically characterized by increased rates of biliary complications and inferior short-term graft survival (GS) compared to donation after brain death (DBD) allografts. This study aimed to evaluate the dynamic prognostic impact of DCD livers to reveal whether they remain an adverse factor even after patients survive a certain period following liver transplant (LT). This study used 74 961 LT patients including 4065 DCD LT in the scientific registry of transplant recipients from 2002-2017.

View Article and Find Full Text PDF
Article Synopsis
  • Hydroxychloroquine (HCQ) is known for its anti-inflammatory properties, and this study evaluates its impact on anti-PD1 immunotherapy in various tumor models (MC38, CT26, RIL-175).
  • The findings indicate that HCQ directly reduces tumor cell growth and negatively affects T-cell production of key cytokines like TNFα and IFNγ, which are important for immune response.
  • HCQ treatment leads to a diminished response to anti-PD1 therapy by impairing T-cell activation and reducing the presence of CD8 T cells that target the tumor, suggesting that HCQ can hinder the effectiveness of this immunotherapy.
View Article and Find Full Text PDF

Delayed-type hypersensitivity (DTH) responses underpin chronic inflammation. Using a model of oxazolone-induced dermatitis and a combination of transgenic mice, adoptive cell transfer, and selective agonists/antagonists against protease activated receptors, we show that that PAR-1 signaling on macrophages by thrombin is required for effective granuloma formation. Using BM-derived macrophages (BMMs) , we show that thrombin signaling induced (a) downregulation of cell membrane reverse cholesterol transporter ABCA1 and (b) increased expression of IFNγ receptor and enhanced co-localization within increased areas of cholesterol-rich membrane microdomains.

View Article and Find Full Text PDF
Article Synopsis
  • Cholangiocarcinomas (CCAs) often show minimal response to immune checkpoint inhibitors (ICIs) like PD-1, prompting researchers to explore the use of a CD40 agonist to enhance immune response.
  • In various murine models of intrahepatic CCAs, combining CD40 agonist therapy with anti-PD-1 treatment significantly reduced tumor burden and boosted the activation of essential immune cells, such as T cells and natural killer cells.
  • The findings suggest that activating macrophages and dendritic cells through CD40 stimulation can improve the effectiveness of anti-PD-1 therapy, particularly when combined with traditional chemotherapy agents like gemcitabine and cisplatin.
View Article and Find Full Text PDF
Article Synopsis
  • Nonalcoholic steatohepatitis (NASH) negatively impacts the effectiveness of immunotherapy against liver tumors in mice, leading to an increase in tumor growth due to a decrease in CD4 T cells.
  • In experiments, while immunotherapies like M30 and aOX40 did inhibit tumor growth in normal mice, they were ineffective in those with steatohepatitis unless treatment with N-acetylcysteine was used to preserve CD4 T cells.
  • The study highlights the role of CD4 T cells in tumor fighting and suggests that targeting steatohepatitis could improve responses to immunotherapy in liver cancer.
View Article and Find Full Text PDF